Roman Butler Fullerton & Co’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,507
Closed -$618K 294
2026
Q1
$618K Buy
2,507
+208
+9% +$46.5K 0.17% 140
2025
Q4
$507K Buy
+2,299
New +$358K 0.13% 166
2024
Q4
Sell
-93,840
Closed -$717K 254
2024
Q3
$717K Buy
93,840
+86,900
+1,252% +$7.56M 0.22% 108
2024
Q2
$783K Buy
6,940
+4,110
+145% +$394K 0.25% 91
2024
Q1
$246K Buy
+2,830
New +$249K 0.09% 191
2021
Q3
Sell
-16,360
Closed -$1.06M 191
2021
Q2
$1.06M Buy
+16,360
New +$1.03M 0.52% 62

Other funds holding LRCX

Roman Butler Fullerton & Co's LRCX Position: Q2 2026 in Review

Roman Butler Fullerton & Co sold out of Lam Research (LRCX) in Q2 2026, closing a stake of 2,507 shares — an estimated $618K sold.

Roman Butler Fullerton & Co first reported a position in LRCX in Q2 2021 and held it in 6 quarters. The position peaked at $1.06M in Q2 2021. 3,137 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Roman Butler Fullerton & Co reported no remaining Lam Research position as of Q2 2026 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 2,507 Lam Research shares in Q2 2026, an estimated $618K.
  • Roman Butler Fullerton & Co first reported a position in Lam Research in Q2 2021 and held it in 6 quarters.
  • Roman Butler Fullerton & Co's Lam Research position peaked at $1.06M in Q2 2021.
  • 3,137 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q2 2026, filed 6 Aug 2026.